Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "jquery" was enqueued with dependencies that are not registered: jquery-migrate. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /var/www/vhosts/hemostasistoday.com/public_html/wp-includes/functions.php on line 6131

Hemostasis Today

February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Pedro Henrique Las Casas: VTE After BCMA Directed CAR T-Cell Therapy in Multiple Myeloma
Feb 3, 2026, 14:33

Pedro Henrique Las Casas: VTE After BCMA Directed CAR T-Cell Therapy in Multiple Myeloma

Pedro Henrique Las Casas, Researcher at Centre de Recherche Saint-Antoine (Sorbonne University–INSERM) and Professor of Internal Medicine at UFMG, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:

“I’m very happy to share the publication of another work in the British Journal of Haematology.

In this systematic review, we evaluated the incidence of venous thromboembolism in multiple myeloma patients treated with BCMA-directed CAR T-cell therapy, highlighting important gaps in reporting and interpretation of real-world data.”

Title: Venous thromboembolism in patients with multiple myeloma treated with B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy: A systematic review

Authors: Pedro Henrique Fernandes do Carmo Las Casas, Javier Marco-Ayala, Elmina-Eleftheria Lefkou, Thamiris Silva Soares, Mohammed A. Baghdadi, Prakasha Kempaiah, Jawed Fareed, Patrick Vandreden, Vania Hungria, Marina Marchetti, Anna Falanga, Laurent Garderet, Grigoris Gerotziafas

Read the Full Article on British Journal  Of Haematology 

Pedro Henrique Las Casas: VTE After BCMA Directed CAR T-Cell Therapy in Multiple Myeloma

Stay updated on all scientific advances with Hemostasis Today.